| Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance | |
| Iwamoto, Hideki; Abe, Mitsuhiko; Yang, Yunlong; Cui, Dongmei; Seki, Takahiro; Nakamura, Masaki; Hosaka, Kayoko; Lim, Sharon; Wu, Jieyu; He, Xingkang | |
| 刊名 | CELL METABOLISM
 |
| 2018 | |
| 卷号 | 28期号:1 |
| ISSN号 | 1550-4131 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3600346 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Iwamoto, Hideki,Abe, Mitsuhiko,Yang, Yunlong,et al. Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance[J]. CELL METABOLISM,2018,28(1). |
| APA | Iwamoto, Hideki.,Abe, Mitsuhiko.,Yang, Yunlong.,Cui, Dongmei.,Seki, Takahiro.,...&Cao, Yihai.(2018).Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance.CELL METABOLISM,28(1). |
| MLA | Iwamoto, Hideki,et al."Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance".CELL METABOLISM 28.1(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论